Gilead Inventory Turnover from 2010 to 2024
| GILD Stock | USD 64.77 0.56 0.86% |
Inventory Turnover | First Reported 2010-12-31 | Previous Quarter 1.77302436 | Current Value 1.52 | Quarterly Volatility 1.45761748 |
Check Gilead Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Gilead main balance sheet or income statement drivers, such as Interest Expense of 534.5 M, Total Revenue of 28.5 B or Gross Profit of 28.5 B, as well as many exotic indicators such as Price To Sales Ratio of 3.54, Dividend Yield of 0.0265 or PTB Ratio of 7.87. Gilead financial statements analysis is a perfect complement when working with Gilead Sciences Valuation or Volatility modules.
Gilead | Inventory Turnover |
Latest Gilead Sciences' Inventory Turnover Growth Pattern
Below is the plot of the Inventory Turnover of Gilead Sciences over the last few years. It is a ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management. Gilead Sciences' Inventory Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Gilead Sciences' overall financial position and show how it may be relating to other accounts over time.
| Inventory Turnover | 10 Years Trend |
|
Inventory Turnover |
| Timeline |
Gilead Inventory Turnover Regression Statistics
| Arithmetic Mean | 2.37 | |
| Geometric Mean | 2.07 | |
| Coefficient Of Variation | 61.56 | |
| Mean Deviation | 0.99 | |
| Median | 2.01 | |
| Standard Deviation | 1.46 | |
| Sample Variance | 2.12 | |
| Range | 5.1572 | |
| R-Value | 0.15 | |
| Mean Square Error | 2.24 | |
| R-Squared | 0.02 | |
| Significance | 0.60 | |
| Slope | 0.05 | |
| Total Sum of Squares | 29.75 |
Gilead Inventory Turnover History
About Gilead Sciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Gilead Sciences income statement, its balance sheet, and the statement of cash flows. Gilead Sciences investors use historical funamental indicators, such as Gilead Sciences's Inventory Turnover, to determine how well the company is positioned to perform in the future. Although Gilead Sciences investors may use each financial statement separately, they are all related. The changes in Gilead Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Gilead Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Gilead Sciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Gilead Sciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Inventory Turnover | 1.77 | 1.52 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Gilead Sciences Correlation against competitors. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Gilead Stock analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Dividend Share 3.02 | Earnings Share 0.36 | Revenue Per Share 22 | Quarterly Revenue Growth 0.053 |
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.